Supportive group holding hands
·
5 Min Read

Time for decisive action on substance-use disorder treatment

Progress is being made to prevent overdose deaths, but about 75,000 lives are still lost annually. The AMA outlines aggressive steps to save more lives.

Behavioral Health
Two colleagues in conversation
UPDATED
·
2 Min Read

Physicians’ progress toward ending the nation’s drug overdose epidemic

Learn more about physicians’ actions toward ending the nation’s overdose epidemic and improving care for patients with pain and substance use disorders (SUD). Download PDF of the Substance Use and Treatment Report.

Behavioral Health
·
3 Min Read

AMA 2025 report on substance use and treatment

New report shows drop in overdose deaths and calls on policymakers to remove obstacles to evidence-based care. 

Press Releases
Doctor prescribing pharmacy to patient
·
4 Min Read

Cross DEA training requirement off your final-year residency checklist

Before you transition to practice, you must complete your MATE Act-required DEA training. An AMA Ed Hub course is tailored for your needs.

series
Transition to Attending
Transitioning to Practice
Person colored with bright psychedelic paint
·
4 Min Read

Nonclinical psilocybin use soars. What should be done now?

A JAMA Psychiatry study shows a sharp increase in use of psilocybin mushrooms. Learn more, plus discover what interests you from across the JAMA Network.

Publications & Newsletters
·
4 Min Read

Top news stories from AMA Morning Rounds®: Week of Oct. 27, 2025

In the news: Stillbirths more common in U.S. than previously reported, GLP-1s show promise in treating substance use disorders and more. 

Publications & Newsletters
·
1 Min Read

Oct. 24, 2025: State Advocacy Update

New issue brief provides kratom and tianeptine basics, AMA recommendations, and more in the latest State Advocacy Update.

Advocacy Update
Naloxone spray
·
5 Min Read

Naloxone can sustain our progress in fighting overdose deaths

Fatal drug overdoses fell 25% last year, sparking hope. Here are five practical steps we should take next to save lives.

series
Leadership
Leadership Viewpoints
Patient reads a prescription
·
3 Min Read

New FDA opioid labeling keep focus on individualized care

Agency action updates medication risk information and supports prescribing decisions tailored to individual patient needs. 

Behavioral Health